Related Experiment Videos
Marked variation in peritoneal insulin absorption in peritoneal dialysis
1Section of Nephrology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.
Summary
Peritoneal insulin absorption varies significantly in patients undergoing continuous ambulatory peritoneal dialysis, but this is not linked to their membrane transport status. Understanding this absorption variability is key for managing intraperitoneal insulin needs.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacokinetics
Background:
- Diabetes management in patients with end-stage renal disease often involves intraperitoneal insulin delivery via peritoneal dialysis.
- Variability in insulin absorption can impact glycemic control and dosing accuracy in these patients.
Purpose of the Study:
- To quantify insulin adsorption to the peritoneal dialysis delivery system.
- To measure the extent of insulin absorption across the peritoneum.
- To determine if peritoneal membrane transport status influences insulin absorption variability.
Main Methods:
- Eight insulin-dependent diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) were enrolled.
- Insulin was added directly to the dialysis fluid.
- Insulin adsorption to the delivery system (bag and tubing) and peritoneal absorption were measured using spent dialysate collection.
Main Results:
- Minimal insulin adsorption (14% ± 5%) to the plastic delivery system was observed.
- Significant inter-patient variability in peritoneal insulin absorption was found (38% ± 14%, range 17%-66%).
- No correlation was identified between membrane transport status and the degree of insulin absorption.
Conclusions:
- Substantial variability exists in the peritoneal absorption of insulin during CAPD.
- This absorption variability contributes to differences in intraperitoneal insulin requirements among patients.
- Peritoneal membrane transport characteristics do not explain the observed variations in insulin absorption.